SEC Company Response from LifeMD, Inc. (LFMD, LFMDP) (CIK 0000948320) (LFMD) — Feb 5, 2013
LifeMD, Inc. (LFMD, LFMDP) (CIK 0000948320)
Date: Feb. 5, 2013 · CIK: 0000948320 · Accession: 0001144204-13-006075
AI Filing Summary & Sentiment
File numbers found in text: 333-184487
Letter
IMMUDYNE, INC.
50 Spring Meadow Road
Mt. Kisco, NY 10549
(914) 244-1777
February 5, 2013
VIA EDGAR
Jeffrey P. Riedler
Assistant Director
Division of Corporation Finance
Mail Stop 4631
U.S. Securities and Exchange Commission
100 F. Street, N.E.
Washington, DC 20549
Re: Immudyne, Inc.
Registration Statement on Form S-1/A
File No. 333-184487
Ladies and Gentlemen:
Pursuant to Rule 461 of the Securities Act of 1933, as amended, Immudyne, Inc., a Delaware corporation (the “Company”), hereby requests that the Securities and Exchange Commission (“SEC”) take appropriate action to cause the above-referenced Registration Statement to become effective on February 6, 2013 at 4:00 p.m., or as soon as practicable thereafter.
The Company acknowledges that:
· Should the SEC or the staff, acting pursuant to delegated authority, declare the registration statement effective, it does not foreclose the SEC from taking any action on the filing;
· The action of the SEC or the staff, acting pursuant to delegated authority, in declaring the registration statement effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the registration statement’s disclosures; and
· The Company may not assert staff comments or the declaration of the registration statement’s effectiveness as a defense in any proceeding initiated by the Commission or any person under the United States federal securities laws.
Mr. Jeffrey P. Riedler
February 5, 2013
Page 2 of 2
Should you have any questions or require any additional information with respect to this filing, please contact Gerald Adler of Newman & Morrison LLP, at (212) 248-1001 or via email at gadler@newmanmorrison.com.
Very truly yours,
IMMUDYNE, INC.
Show Raw Text
CORRESP
1
filename1.htm
IMMUDYNE, INC.
50 Spring Meadow Road
Mt. Kisco, NY 10549
(914) 244-1777
February 5, 2013
VIA EDGAR
Jeffrey P. Riedler
Assistant Director
Division of Corporation Finance
Mail Stop 4631
U.S. Securities and Exchange Commission
100 F. Street, N.E.
Washington, DC 20549
Re: Immudyne, Inc.
Registration Statement on Form S-1/A
File No. 333-184487
Ladies and Gentlemen:
Pursuant to Rule 461 of the Securities Act
of 1933, as amended, Immudyne, Inc., a Delaware corporation (the “Company”), hereby requests that the Securities and
Exchange Commission (“SEC”) take appropriate action to cause the above-referenced Registration Statement to become
effective on February 6, 2013 at 4:00 p.m., or as soon as practicable thereafter.
The Company acknowledges that:
· Should the SEC or the staff, acting pursuant to delegated authority, declare the registration statement effective, it does
not foreclose the SEC from taking any action on the filing;
· The action of the SEC or the staff, acting pursuant to delegated authority, in declaring the registration statement effective,
does not relieve the Company from its full responsibility for the adequacy and accuracy of the registration statement’s disclosures;
and
· The Company may not assert staff comments or the declaration of the registration statement’s effectiveness as a defense
in any proceeding initiated by the Commission or any person under the United States federal securities laws.
Mr. Jeffrey P. Riedler
February 5, 2013
Page 2 of 2
Should you have any questions or require
any additional information with respect to this filing, please contact Gerald Adler of Newman & Morrison LLP, at (212) 248-1001
or via email at gadler@newmanmorrison.com.
Very truly yours,
IMMUDYNE, INC.
/s/ Mark McLaughlin
By: Mark McLaughlin, President
cc: Gerald Adler, Newman & Morrison LLP